4 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
ABT Abbott Laboratories $67.67 $118.71B N/A
Article Searches
Abbott Partners With Sanofi to Upgrade Diabetes Management http://www.zacks.com/stock/news/522662/abbott-partners-with-sanofi-to-upgrade-diabetes-management?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-522662 Sep 17, 2019 - Abbott (ABT) collaborates with Sanofi to revolutionize diabetes care through technological advancements.
Here's Why You Should Hold on to Thermo Fisher (TMO) for Now http://www.zacks.com/stock/news/499537/heres-why-you-should-hold-on-to-thermo-fisher-tmo-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-499537 Sep 03, 2019 - Investors continue to be optimistic about Thermo Fisher's (TMO) performance.
Abbott Receives European Nod for Pediatric Heart Devices http://www.zacks.com/stock/news/524246/abbott-receives-european-nod-for-pediatric-heart-devices?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-524246 Sep 18, 2019 - Abbott (ABT) aims to offer better treatment options for the most vulnerable patient population.
CGM Devices Gain Steam, Set New Trend in Diabetes Management http://www.zacks.com/stock/news/527773/cgm-devices-gain-steam-set-new-trend-in-diabetes-management?cid=CS-ZC-FT-analyst_blog|industry_focus-527773 Sep 20, 2019 - The FDA authorization classifies the new type of CGM devices in class II and subjects these to certain criteria called special controls.

Pages: 1

Page 1